Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) CFO Tighe Reardon sold 822,721 shares of the stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $54.75, for a total value of $45,043,974.75. Following the sale, the chief financial officer now directly owns 633,673 shares of […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) major shareholder Ventures Xi L.P. Avalon sold 677,279 shares of Janux Therapeutics stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $54.75, for a total value of $37,081,025.25. Following the transaction, the insider now directly owns 3,271,216 shares of […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) major shareholder Ventures Xi L.P. Avalon sold 677,279 shares of Janux Therapeutics stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $54.75, for a total value of $37,081,025.25. Following the transaction, the insider now directly owns 3,271,216 shares of […]
Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) traded down 6.1% during trading on Thursday . The company traded as low as $7.32 and last traded at $7.35. 219,510 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 1,230,257 shares. The stock had previously closed at […]
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) Director Daniel K. Spiegelman sold 3,788 shares of Myriad Genetics stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $22.04, for a total transaction of $83,487.52. Following the sale, the director now directly owns 36,705 shares in the company, […]